Eurofins Scientific SE
ERFSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,655,915 | $14,036,214 | $13,013,967 | $21,389,132 |
| - Cash | $613,900 | $1,221,200 | $486,600 | $515,300 |
| + Debt | $3,610,300 | $3,926,500 | $3,325,500 | $2,754,100 |
| Enterprise Value | $12,652,315 | $16,741,514 | $15,852,867 | $23,627,932 |
| Revenue | $6,951,000 | $6,514,600 | $6,712,100 | $6,717,700 |
| % Growth | 6.7% | -2.9% | -0.1% | – |
| Gross Profit | $4,712,200 | $1,374,700 | $4,485,100 | $4,568,000 |
| % Margin | 67.8% | 21.1% | 66.8% | 68% |
| EBITDA | $1,366,900 | $1,217,000 | $1,352,500 | $1,541,500 |
| % Margin | 19.7% | 18.7% | 20.2% | 22.9% |
| Net Income | $406,400 | $310,200 | $610,200 | $782,600 |
| % Margin | 5.8% | 4.8% | 9.1% | 11.6% |
| EPS Diluted | 2.09 | 1.3 | 3.07 | 3.9 |
| % Growth | 60.8% | -57.7% | -21.3% | – |
| Operating Cash Flow | $1,318,900 | $1,017,900 | $1,136,300 | $1,509,800 |
| Capital Expenditures | -$528,400 | -$550,100 | -$660,200 | -$519,500 |
| Free Cash Flow | $790,500 | $467,800 | $476,100 | $990,300 |